- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/50 - Coronaviridae, e.g. infectious bronchitis virus, transmissible gastroenteritis virus
Patent holdings for IPC class C12N 15/50
Total number of patents in this class: 385
10-year publication summary
|
1
|
1
|
0
|
3
|
52
|
80
|
61
|
37
|
12
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Guangzhou N Biomed Ltd. | 21 |
7 |
| Westvac Biopharma Co., Ltd. | 26 |
6 |
| Fudan University | 728 |
5 |
| The Research Foundation for Microbial Diseases of Osaka University | 67 |
5 |
| Institute of Microbiology, Chinese Academy of Sciences | 125 |
4 |
| Oncotherapy Science, Inc. | 257 |
4 |
| Osaka University | 3355 |
4 |
| The University of Tokyo | 4297 |
4 |
| Cansino Biologics Inc. | 81 |
4 |
| Providence Therapeutics Holdings Inc. | 22 |
4 |
| Shanghai Rnacure Biopharma Co., Ltd. | 16 |
4 |
| Council of Scientific & Industrial Research | 1431 |
3 |
| Denka Company Limited | 2680 |
3 |
| Kanto Kagaku Kabushiki Kaisha | 91 |
3 |
| Public University Corporation Yokohama City University | 240 |
3 |
| Toyobo Co., Ltd. | 2491 |
3 |
| Universite Laval | 707 |
3 |
| Suzhou Abogen Biosciences Co., Ltd. | 76 |
3 |
| Cancer Precision Medicine, Inc. | 6 |
3 |
| Shenzhen Shenxin Biotechnology Co., Ltd. | 35 |
3 |
| Other owners | 307 |